BLADDER SQUAMOUS CELL CARCINOMA STAGE UNSPECIFIED

This adverse event was reported 35 times

These drugs are most commonly taken by patients reporting BLADDER SQUAMOUS CELL CARCINOMA STAGE UNSPECIFIED:

# Drug Count
0 PIOGLITAZONE 6
1 LENALIDOMIDE 3
2 NATALIZUMAB 3
3 ASPIRIN 2
4 ASPIRIN 325 MG 2
5 ASPIRIN 81 MG 2
6 ATORVASTATIN CALCIUM 2
7 CARBOPLATIN 2
8 CHLORAMBUCIL 2
9 CYCLOSPORINE 2
See all common drugs associated with BLADDER SQUAMOUS CELL CARCINOMA STAGE UNSPECIFIED

BLADDER SQUAMOUS CELL CARCINOMA STAGE UNSPECIFIED is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 DARIFENACIN HYDROBROMIDE 1 0.0012
1 MIGLITOL 1 0.0010
2 PIOGLITAZONE AND METFORMIN HYDROCHLORIDE 1 0.0008
3 CHLORAMBUCIL 2 0.0005
4 MINOCYCLINE HYDROCHLORIDE 2 0.0003
5 PALONOSETRON HYDROCHLORIDE 1 0.0002
6 LORATADINE PSEUDOEPHEDRINE SULFATE 1 0.0002
7 HUMAN INSULIN 1 0.0001
8 PIOGLITAZONE 6 0.0001
9 LORATADINE AND PSEUDOEPHEDRINE SULFATE 1 0.0001
See all drugs enriched for association with BLADDER SQUAMOUS CELL CARCINOMA STAGE UNSPECIFIED

BLADDER SQUAMOUS CELL CARCINOMA STAGE UNSPECIFIED is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 alpha-Glucosidase Inhibitor [EPC] 1 0.0002
1 Provitamin D2 Compound [EPC] 2 0.0001
2 PCSK9 Inhibitor [EPC] 1 0.0000
3 Integrin Receptor Antagonist [EPC] 3 0.0000
4 Interleukin-17A Antagonist [EPC] 1 0.0000
5 Cholinergic Muscarinic Antagonist [EPC] 1 0.0000
6 Insulin [EPC] 1 0.0000
7 Interleukin-12 Antagonist [EPC] 2 0.0000
8 Interleukin-23 Antagonist [EPC] 2 0.0000
9 Complement Inhibitor [EPC] 1 0.0000
See all drug classes enriched for association with BLADDER SQUAMOUS CELL CARCINOMA STAGE UNSPECIFIED